This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

BRICE

  • Research type

    Research Study

  • Full title

    Burden of RSV Infection in young Children in European countries (BRICE study)

  • IRAS ID

    294308

  • Contact name

    Atul Gupta

  • Contact email

    atulgupta1@nhs.net

  • Sponsor organisation

    Merck Sharp & Dohme Corp

  • Duration of Study in the UK

    2 years, 4 months, 31 days

  • Research summary

    This is a multi center, international, prospective, observational study of children ≤2 years of age who have been hospitalized with Respiratory Syncytial Virus (RSV). The aim of the study is to estimate the population based incidence rate of RSV hospitalization and to understand the burdens associated of RSV.

    The study will be comprised of two parts: A total 200 participants per country will be enrolled in the RSV Hospitalization Impact Survey Study and approximately 100 enrolled per country for the Wheezing Follow Up Study.

    The study will be conducted in the United Kingdom, France, Germany, Spain and Italy with 1 NHS site in England.

    The total study duration will be from October 2020 to May 2023. Enrolment will occur from October 2020 to May 2022 during two RSV seasons. There will be a 12 month follow up period which will end in May 2023

  • REC name

    London - Brighton & Sussex Research Ethics Committee

  • REC reference

    21/PR/0095

  • Date of REC Opinion

    15 Feb 2021

  • REC opinion

    Unfavourable Opinion